Proteins regulating cap-dependent translation are downregulated during total knee Arthroplasty

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 302, Issue 6, 2012, Pages 702-711

  Ratchford, Stephen M ^a   Bailey, Ashley N ^a   Senesac, Hilary A ^a   Hocker, Austin D ^a   Smolkowski, Keith ^b   Lantz, Brick A ^c   Jewett, Brian A ^c   Gilbert, Jeffrey S ^a   Dreyer, Hans C ^a  

^a UNIVERSITY OF OREGON   (United States)

^b OREGON RESEARCH INSTITUTE   (United States)

^c Slocum Center for Orthopedics and Sports Medicine   (United States)

Author keywords

4E binding protein 1; Activating transcription factor 4; Arrest; Atrophy; DNA damage; Growth; Muscle; Tourniquet

Indexed keywords

ELONGATION FACTOR; EUKARYOTIC ELONGATION FACTOR 2; INITIATION FACTOR 4E BINDING PROTEIN 1; PROTEIN KINASE B; SERINE; THREONINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENETIC TRANSCRIPTION AND TRANSLATION; HUMAN; HUMAN TISSUE; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE ISCHEMIA; MUSCLE MASS; ORTHOPEDIC EQUIPMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUADRICEPS FEMORIS MUSCLE; REPERFUSION INJURY; TOTAL KNEE REPLACEMENT; TOURNIQUET; TRANSLATION INITIATION; TRANSLATION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; ARTHROPLASTY, REPLACEMENT, KNEE; BIOPSY; DOWN-REGULATION; ELONGATION FACTOR 2 KINASE; EUKARYOTIC INITIATION FACTOR-2; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; OSTEOARTHRITIS, KNEE; PHOSPHOPROTEINS; PROTEIN BIOSYNTHESIS; REPERFUSION INJURY; RETROSPECTIVE STUDIES;

EID: 84858225055     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00601.2011     Document Type: Article

References (60)

1. Abadi A, Glover EI, Isfort RJ, Raha S, Safdar A, Yasuda N, Kaczor JJ, Melov S, Hubbard A, Qu X, Phillips SM, Tarnopolsky M. Limb immobilization induces a coordinate down-regulation of mitochondrial and other metabolic pathways in men and women. PLos One 4: e6518, 2009.
2. Appell HJ, Gloser S, Duarte JA, Zellner A, Soares JM. Skeletal muscle damage during tourniquet-induced ischaemia. The initial step towards atrophy after orthopaedic surgery? Eur J Appl Physiol Occup Physiol 67: 342-347, 1993.
3. Arsham AM, Howell JJ, Simon MC. A novel hypoxia-inducible factorindependent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem 278: 29655-29660, 2003.
4. Blais JD, Filipenko V, Bi M, Harding HP, Ron D, Koumenis C, Wouters BG, Bell JC. Activating transcription factor 4 is translationally regulated by hypoxic stress. Mol Cell Biol 24: 7469-7482, 2004.
5. Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg 10: 620-630, 2002.
6. Bolster DR, Crozier SJ, Kimball SR, Jefferson LS. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 277: 23977-23980, 2002.
7. Brush MH, Shenolikar S. Control of cellular GADD34 levels by the 26S proteasome. Mol Cell Biol 28: 6989-7000, 2008.
8. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-622, 2009.
9. Carlberg U, Nilsson A, Nygard O. Functional properties of phosphorylated elongation factor 2. Eur J Biochem 191: 639-645, 1990.
10. Centers for Disease Control and Prevention. Prevalence and most common causes of disability among adults-United States, 2005. MMWR Morb Mortal Wkly Rep 58: 421-426, 2009.
11. Clemens MJ, Bushell M, Morley SJ. Degradation of eukaryotic polypeptide chain initiation factor (eIF) 4G in response to induction of apoptosis in human lymphoma cell lines. Oncogene 17: 2921-2931, 1998.
12. Connolly EP, Thuillier V, Rouy D, Bouetard G, Schneider RJ. Inhibition of Cap-initiation complexes linked to a novel mechanism of eIF4G depletion in acute myocardial ischemia. Cell Death Differ 13: 1586-1594, 2006.
13. Constantin D, McCullough J, Mahajan RP, Greenhaff PL. Novel events in the molecular regulation of muscle mass in critically ill patients. J Physiol 589: 3883-3895, 2011.
14. Crozier SJ, Vary TC, Kimball SR, Jefferson LS. Cellular energy status modulates translational control mechanisms in ischemic-reperfused rat hearts. Am J Physiol Heart Circ Physiol 289: H1242-H1250, 2005.
15. Dreyer HC, Drummond MJ, Pennings B, Fujita S, Glynn EL, Chinkes DL, Dhanani S, Volpi E, Rasmussen BB. Leucine-enriched essential amino acid and carbohydrate ingestion following resistance exercise enhances mTOR signaling and protein synthesis in human muscle. Am J Physiol Endocrinol Metab 294: E392-E400, 2008.
16. Dreyer HC, Fujita S, Cadenas JG, Chinkes DL, Volpi E, Rasmussen BB. Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle. J Physiol 576: 613-624, 2006.
17. Drummond MJ, Miyazaki M, Dreyer HC, Pennings B, Dhanani S, Volpi E, Esser KA, Rasmussen BB. Expression of growth-related genes in young and older human skeletal muscle following an acute stimulation of protein synthesis. J Appl Physiol 106: 1403-1411, 2009.
18. Duarte JA, Gloser S, Remiao F, Carvalho F, Bastos ML, Soares JM, Appell HJ. Administration of tourniquet. I. Are edema and oxidative stress related to each other and to the duration of ischemia in reperfused skeletal muscle? Arch Orthop Trauma Surg 116: 97-100, 1997.
19. Ebert SM, Monteys AM, Fox DK, Bongers KS, Shields BE, Malmberg SE, Davidson BL, Suneja M, Adams CM. The transcription factor ATF4 promotes skeletal myofiber atrophy during fasting. Mol Endocrinol 24: 790-799, 2010.
20. Finch E, Walsh M, Thomas SG, Woodhouse LJ. Functional ability perceived by individuals following total knee arthroplasty compared to age-matched individuals without knee disability. J Orthop Sports Phys Ther 27: 255-263, 1998.
21. Gebauer F, Hentze MW. Molecular mechanisms of translational control. Nat Rev Mol Cell Biol 5: 827-835, 2004.
22. Gingras AC, Kennedy SG, O'Leary MA, Sonenberg N, Hay N. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev 12: 502-513, 1998.
23. Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, Ron D. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6: 1099-1108, 2000.
24. Holcik M, Sonenberg N. Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 6: 318-327, 2005.
25. Hootman JM, Sniezek JE, Helmick CG. Women and arthritis: burden, impact and prevention programs. J Womens Health Gend Based Med 11: 407-416, 2002.
26. Johannes G, Sarnow P. Cap-independent polysomal association of natural mRNAs encoding c-myc, BiP, and eIF4G conferred by internal ribosome entry sites. RNA 4: 1500-1513, 1998.
27. Kanji GK. 100 Statistical Tests. Thousand Oaks, CA: Sage, 1999.
28. Kaul G, Pattan G, Rafeequi T. Eukaryotic elongation factor-2 (eEF2): its regulation and peptide chain elongation. Cell Biochem Funct 29: 227-234, 2011.
29. Koritzinsky M, Magagnin MG, van den Beucken T, Seigneuric R, Savelkouls K, Dostie J, Pyronnet S, Kaufman RJ, Weppler SA, Voncken JW, Lambin P, Koumenis C, Sonenberg N, Wouters BG. Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J 25: 1114-1125, 2006.
30. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89: 780-785, 2007.
31. Liu L, Cash TP, Jones RG, Keith B, Thompson CB, Simon MC. Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol Cell 21: 521-531, 2006.
32. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
33. Losina E, Walensky RP, Kessler CL, Emrani PS, Reichmann WM, Wright EA, Holt HL, Solomon DH, Yelin E, Paltiel AD, Katz JN. Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch Intern Med 169: 1113-1121; discussion 1121-1112, 2009.
34. Marissen WE, Gradi A, Sonenberg N, Lloyd RE. Cleavage of eukaryotic translation initiation factor 4GII correlates with translation inhibition during apoptosis. Cell Death Differ 7: 1234-1243, 2000.
35. Martin ME, Munoz FM, Salinas M, Fando JL. Ischaemia induces changes in the association of the binding protein 4E-BP1 and eukaryotic initiation factor (eIF) 4G to eIF4E in differentiated PC12 cells. Biochem J 351: 327-334, 2000.
36. Meier WA, Marcus RL, Dibble LE, Foreman KB, Peters CL, Mizner RL, LaStayo PC. The long-term contribution of muscle activation and muscle size to quadriceps weakness following total knee arthroplasty. J Geriatr Phys Ther 32: 35-38, 2009.
37. Mizner RL, Petterson SC, Snyder-Mackler L. Quadriceps strength and the time course of functional recovery after total knee arthroplasty. J Orthop Sports Phys Ther 35: 424-436, 2005.
38. Mizner RL, Petterson SC, Stevens JE, Axe MJ, Snyder-Mackler L. Preoperative quadriceps strength predicts functional ability one year after total knee arthroplasty. J Rheumatol 32: 1533-1539, 2005.
39. Mizner RL, Petterson SC, Stevens JE, Vandenborne K, Snyder-Mackler L. Early quadriceps strength loss after total knee arthroplasty. The contributions of muscle atrophy and failure of voluntary muscle activation. J Bone Joint Surg Am 87: 1047-1053, 2005.
40. Mizner RL, Snyder-Mackler L. Altered loading during walking and sit-to-stand is affected by quadriceps weakness after total knee arthroplasty. J Orthop Res 23: 1083-1090, 2005.
41. Novoa I, Zeng H, Harding HP, Ron D. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J Cell Biol 153: 1011-1022, 2001.
42. Novoa I, Zhang Y, Zeng H, Jungreis R, Harding HP, Ron D. Stressinduced gene expression requires programmed recovery from translational repression. EMBO J 22: 1180-1187, 2003.
43. Ouellet D, Moffet H. Locomotor deficits before and two months after knee arthroplasty. Arthritis Rheum 47: 484-493, 2002.
44. Parsley BS, Bertolusso R, Harrington M, Brekke A, Noble PC. Influence of gender on age of treatment with TKA and functional outcome. Clin Orthop Relat Res 468: 1759-1764, 2010.
45. Proud CG. Regulation of mammalian translation factors by nutrients. Eur J Biochem 269: 5338-5349, 2002.
46. Racz IB, Illyes G, Sarkadi L, Hamar J. The functional and morphological damage of ischemic reperfused skeletal muscle. Eur Surg Res 29: 254-263, 1997.
47. Raught B, Gingras AC, Gygi SP, Imataka H, Morino S, Gradi A, Aebersold R, Sonenberg N. Serum-stimulated, rapamycin-sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI. EMBO J 19: 434-444, 2000.
48. Reginster JY, Khaltaev NG. Introduction and WHO perspective on the global burden of musculoskeletal conditions. Rheumatology (Oxford) 41, Suppl 1: 1-2, 2002.
49. Saghir AN, Tuxworth WJ Jr, Hagedorn CH, McDermott PJ. Modifications of eukaryotic initiation factor 4F (eIF4F) in adult cardiocytes by adenoviral gene transfer: differential effects on eIF4F activity and total protein synthesis rates. Biochem J 356: 557-566, 2001.
50. Scheper GC, Proud CG. Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation? Eur J Biochem 269: 5350-5359, 2002.
51. Sexton WL, Korthuis RJ, Laughlin MH. Microvascular injury after ischemia and reperfusion in skeletal muscle of exercise-trained rats. J Appl Physiol 68: 2329-2336, 1990.
52. Sternbergh WC, 3rd, Adelman B. The temporal relationship between endothelial cell dysfunction and skeletal muscle damage after ischemia and reperfusion. J Vasc Surg 16: 30-39, 1992.
53. Suval WD, Duran WN, Boric MP, Hobson RW, 3rd Berendsen PB, Ritter AB. Microvascular transport and endothelial cell alterations preceding skeletal muscle damage in ischemia and reperfusion injury. Am J Surg 154: 211-218, 1987.
54. Suval WD, Hobson RW, 2nd Boric MP, Ritter AB, Duran WN. Assessment of ischemia reperfusion injury in skeletal muscle by macromolecular clearance. J Surg Res 42: 550-559, 1987.
55. Taylor S, Wakem M, Dijkman G, Alsarraj M, Nguyen M. A practical approach to RT-qPCR-Publishing data that conform to the MIQE guidelines. Methods 50: S1-S5, 2010.
56. Vary TC, Kimball SR. Sepsis-induced changes in protein synthesis: differential effects on fast- and slow-twitch muscles. Am J Physiol Cell Physiol 262: C1513-C1519, 1992.
57. Walsh M, Woodhouse LJ, Thomas SG, Finch E. Physical impairments and functional limitations: a comparison of individuals 1 year after total knee arthroplasty with control subjects. Phys Ther 78: 248-258, 1998.
58. Whitney ML, Jefferson LS, Kimball SR. ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression. Biochem Biophys Res Commun 379: 451-455, 2009.
59. Wouters BG, van den Beucken T, Magagnin MG, Koritzinsky M, Fels D, Koumenis C. Control of the hypoxic response through regulation of mRNA translation. Semin Cell Dev Biol 16: 487-501, 2005.
60. Yoshida Y, Mizner RL, Ramsey DK, Snyder-Mackler L. Examining outcomes from total knee arthroplasty and the relationship between quadriceps strength and knee function over time. Clin Biomech 23: 320-328, 2008.